Related Experiment Video
Updated: Mar 19, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Value of ABCD2-F in Predicting Cerebral Ischemic Attacks: Three Months Follow-Up after the Primary Attack
Mojtaba Chardoli1, Nader H Firoozabadi1, Mohsen Nouri2
1Department of Emergency Medicine, Haftom-e-Tir Hospital, Iran University of Medical Sciences, Tehran, Iran.
Insights
Adding atrial fibrillation to the ABCD2 score did not improve its ability to predict repeat cerebrovascular attacks (CVA) or transient ischemic attacks (TIA). This modified ABCD2-F score did not enhance risk assessment for recurrent ischemic events.
Area of Science:
- Neurology
- Cardiology
- Emergency Medicine
Background:
- Cerebrovascular attack (CVA) and transient ischemic attack (TIA) are significant causes of emergency department visits globally.
- Untreated patients face a high risk of recurrent ischemic events.
- Existing risk stratification tools, like the ABCD2 score, aim to identify high-risk individuals.
Purpose of the Study:
- To enhance the sensitivity and specificity of the ABCD2 score for predicting recurrent ischemic attacks.
- To evaluate the efficacy of the modified ABCD2-F score, incorporating atrial fibrillation as an additional criterion.
Main Methods:
- A prospective study involving 138 patients diagnosed with TIA/CVA across two hospitals.
- Collection of demographic, clinical, and paraclinical data.
- Three-month follow-up to monitor for recurrent ischemic attacks.
Main Results:
- Recurrent ischemic attacks occurred in 9.4% of the study cohort.
- No individual criterion of the ABCD2-F score was associated with an increased risk of ischemic attacks.
- The ABCD2-F score did not significantly differ between patients with and without recurrent cerebral ischemia.
Conclusions:
- The addition of atrial fibrillation to the ABCD2 score (ABCD2-F) did not improve its accuracy in identifying patients at high risk for recurrent cerebral ischemia.
- Further research is warranted to develop more sensitive and specific risk stratification tools for TIA/CVA patients.
Abstract:
Cerebrovascular attack (CVA) and transient ischemic attack (TIA) are major causes of emergency department visits around the globe. A significant number of these patients may experience repeat attacks if left untreated. Several risk stratifying scoring systems have been developed in recent years to point out the high risk patients. ABCD2 is based on age, blood pressure, clinical status, diabetes mellitus, and duration of symptoms and is used commonly for this purpose. In this study, we were to enhance its sensitivity and specificity with the addition of another criterion namely atrial fibrillation and making ABCD2-F. A prospective study in two hospitals was performed and 138 patients diagnosed with TIA/CVA were enrolled. Demographic, clinical, and paraclinical data of all patients were registered. All patients were followed for three months for any sign or symptom of a recurrent ischemic attack. Recurrent ischemic attacks happened in 9.4% of the patients. None of the criteria of ABCD2-F was associated with higher chance of ischemic attacks. Similarly, ABCD2-F was not different between patients with or without repeat cerebral ischemia. The addition of atrial fibrillation to ABCD2 did not enhance the accuracy of this scoring system to detect patients high risk for repeat cerebral ischemia. More studies in the future to improve sensitivity and specificity of this test are warranted.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests